Risk analysis of cold ischemia time (CIT) in liver transplantation has largely focused on patient and graft survival. Posttransplant length of stay is a sensitive marker of morbidity and cost. We hypothesize that CIT is a risk factor for posttransplant prolonged length of stay (PLOS) and aim to conduct an hour-by-hour analysis of CIT and PLOS. We retrospectively reviewed all adult, first-time liver transplants between March 2002 and September 2016 in the United Network for Organ Sharing database. The 67,426 recipients were categorized by hourly CIT increments. Multivariate logistic regression of PLOS (defined as >30 days), CIT groups, and an extensive list of confounding variables was performed. Linear regression between length of stay and CIT as continuous variables was also performed. CIT 1-6 hours was protective against PLOS, whereas CIT >7 hours was associated with increased odds for PLOS. The lowest odds for PLOS were observed with 1-2 hours (odds ratio [OR], 0.65; 95% confidence interval [CI], 0.45-0.92) and 2-3 hours (OR, 0.65; 95% CI, 0.55-0.78) of CIT. OR for PLOS steadily increased with increasing CIT, reaching the greatest odds for PLOS with 13-14 hours (OR, 2.05; 95% CI, 1.57-2.67) and 15-16 hours (OR, 2.06; 95% CI, 1.27-3.33) of CIT. Linear regression revealed a positive correlation between length of stay and CIT with a correlation coefficient of 10.35 (P < 0.001). In conclusion, post-liver transplant length of stay is sensitive to CIT, with a substantial increase in the odds of PLOS observed with nearly every additional hour of cold ischemia. We conclude that CIT should be minimized to protect against the morbidity and cost associated with posttransplant PLOS.
Liver transplantation is currently the only definitive treatment for liver failure. Obtaining high-quality grafts is vital to ensuring successful posttransplant outcomes. Cold ischemia time (CIT) has been widely regarded as a donor-related risk factor and is defined as the time from cross-clamping of the donor liver to removal of the organ from cold storage solution. CIT has been incorporated into scoring systems such as the donor risk index, which is used to quantifiably predict graft failure associated with poor-quality organs. (1) However, risk analysis extending beyond graft and patient survival measures is lacking. Prolonged length of stay (PLOS), for example, is a sensitive measure of morbidity and cost that is dependent on a multitude of patient and donor factors. (2) (3) (4) (5) (6) (7) Analyzing the effect of pretransplant factors on PLOS then offers the opportunity to preoperatively risk stratify cases and prevent futile transplantations with high morbidity and wasted resources.
Within the existing literature, few studies have used PLOS as an outcome measure of CIT. Furthermore, past analyses of CIT have used arbitrary categories and cutoffs for this continuous measure with little basis for said cutoff selections. The aim of this study is to conduct a rigorous hourly risk analysis to objectively determine the association between CIT and liver transplant outcomes, including patient survival, graft survival, and posttransplant PLOS. We hypothesize that risk of PLOS will be most robustly affected by increasing CIT.
Patients and Methods

STUDY POPULATION
Following approval from our institutional review board, we retrospectively reviewed the United Network for Organ Sharing database to identify all liver transplants performed between March 2002 (the start of the Model for End-Stage Liver Disease [MELD] era) and September 2016. Recipients younger than 18 years (n 5 8236), retransplants (n 5 5533), simultaneous multiorgan transplants (n 5 5855), and living donor transplants (n 5 3275) were excluded, as were recipients without a follow-up time (n 5 173) or CIT (n 5 3066) available in the database. The remaining 67,426 recipients were included in the analysis.
STATISTICAL ANALYSIS
Recipients were categorized based on 1-hour increments of CIT, starting with 1 hour through over 16 hours (eg, CIT 1 hour, 1-2 hours . . . 15-16 hours, >16 hours), with the upper value being inclusive for each group. The outcomes of interest were patient survival, graft survival, and posttransplant PLOS. PLOS was defined as posttransplant hospital stay of >30 days, as previously defined in the literature. (2) A multivariate time-to-event survival Cox regression was performed for patient and graft survival, with the CIT group encompassing the median CIT for the whole cohort set as the reference group. All other CIT groups were forced into the multivariate model. Follow-up time was calculated in years from the date of transplantation to the date of graft failure or last-known follow-up. For analysis of patient survival, recipients were followed from time of transplant to death (n 5 16,878) or date of last-known follow-up (n 5 50,548). For graft survival, recipients were followed from time of transplant to graft failure (n 5 20,103), defined as death or retransplantation, or last-known follow-up (n 5 47,323). For analysis of PLOS, a multivariate logistic regression was performed. Recipients without a discharge date (n 5 784) and those who were retransplanted (n 5 854) or died (n 5 1677) within 30 days of transplantation were excluded from the PLOS analysis. Similar to the survival analysis, the CIT group encompassing the median value was set as the reference, and all other CIT groups were forced into the regression. Lastly, a linear regression was performed between posttransplant length of stay and CIT as continuous variables in days and hours, respectively. Recipients without a discharge date (n 5 784) or who died or were retransplanted prior to discharge (n 5 833) were excluded from the linear regression analysis.
An extensive list of potential confounding recipient and donor factors were considered ( Table 1) . Any of these factors that were found to be significantly associated with the outcome of interest were included in the multivariate analysis. This was performed individually for patient mortality, graft loss, PLOS, and length of stay. For categorical confounding variables with missing values, the missing values were included in the reference group with the assumption that the particular Additional supporting information may be found in the online version of this article.
risk factor was more likely to be not present if it was not documented in the database and that the missing values were randomly distributed with respect to the outcome of interest. Chained multiple imputation was performed for significant continuous confounding variables with missing values.
All statistical analysis was done using Stata, version 13.0 (StataCorp, College Station, TX). A P value < 0.05 was set as statistically significant for all tests.
Results
STUDY POPULATION
In total, 67,426 recipients underwent a first liver transplant during the study period and met the inclusion criteria. Median follow-up time for this cohort was 3.49 years (interquartile range [IQR], 1.01-7.00 years). The descriptive statistics and percentage of missing values for this cohort are summarized in Table 2 . The distribution of recipients across the CIT groups is illustrated in Fig. 1 .
PATIENT MORTALITY AND GRAFT LOSS
The median CIT for the study cohort was 6.4 hours, so the 6-7 hours CIT group was set as the reference group for the Cox regression. The results of the univariate and multivariate Cox regression of patient mortality are summarized in Supporting Tables 1 and 2 , respectively. Upon multivariate Cox regression, CIT (Fig. 2) . The greatest risk was observed with 12-13 hours (HR, 1.26; 95% CI, 1.12-1.41). The results of the univariate and multivariate Cox regression of graft loss are summarized in Supporting Tables 3 and 4 , respectively. Upon multivariate Cox regression, CIT between 2-3 and 4-6 hours was protective against graft loss, whereas CIT between 9 and 16 hours was associated with significantly increased risk for graft loss compared with the reference group of 6-7 hours (Fig. 3) 
PROLONGED LENGTH OF STAY
There were 64,111 recipients who met the inclusion criteria for the analysis of PLOS. Among this subgroup, the median CIT was 6.8 hours, so the 6-7 hours CIT group was set as the reference group for the logistic regression. The results of the univariate and multivariate logistic regression of PLOS are summarized in Supporting Tables 5 and 6 , respectively. Upon multivariate logistic regression, CIT between 1 and 6 hours was protective against PLOS, whereas CIT of >7 hours was associated with significantly increased odds for PLOS compared with the reference group of 6-7 hours (Fig. 4) Tables 7 and 8 , respectively. Multivariate linear regression revealed a positive correlation between length of stay and CIT with a correlation coefficient of 10.35 (P < 0.001).
Discussion
In this retrospective review of over 60,000 liver transplants, we found that longer CIT was strongly associated with increased risk for PLOS. Although graft survival was only weakly impacted by CIT, demonstrating a peak HR of 1.33 at 15-16 hours of CIT, PLOS was robustly impacted by increasing CIT, with The causes of prolonged CIT are numerous and multifactorial. Transportation time is a commonly cited component of total CIT with a farther distance between donor and recipient sites increasing the total CIT. (8, 9) However, additional logistical variables may contribute. A study investigating in-hospital causes of CIT where livers were harvested and transplanted within the same facility revealed a host of additional associations. Factors correlating with increased CIT included donation after circulatory death (DCD), donor biopsy, male recipient, recipient obesity, retransplant recipients, transplant center variation, and organ procurement organization variation. In contrast, sicker patients with MELD >29 or listing status 1a were associated with decreased CIT. (10) Our multivariate analysis accounted for 30 potential confounders, including DCD, recipient sex, body mass index (BMI), MELD, and listing status.
Prior literature reports the effect of CIT primarily in terms of patient and graft survival. These measures have been inconsistently shown to decrease with increasing CIT. A study by Furukawa et al. reported decreased graft but not patient survival in cases of prolonged CIT. (11) In this study, CIT of >15 hours was associated with decreased graft survival in the first 14 days of transplant, and CIT of >20 hours was associated with increased graft primary nonfunction. (11) A meta-analysis of 26 studies also identified an association between CIT and poor outcome measures, including primary nonfunction, decreased patient survival, and decreased graft survival. (12) Interestingly, their regression analysis of CIT and transplant outcomes revealed a quadratic relationship. The best outcomes occurred in the moderate CIT range from 7.5 to 12.5 hours, and poor outcomes occurred in both the shorter and longer CIT intervals. The authors hypothesized that the process of organ allocation was responsible for the nonlinear relationship in their study, in which organs with very low CIT were reserved for critically ill patients with little reserve and organs with prolonged CIT were used in desperate situations for patients with few options. Finally, some studies have failed to identify any significant relationship between CIT and either graft or patient survival. (8, 13) These inconsistent findings may reflect the lack of robust association between CIT and survival measures. Our risk analysis also revealed inconsistent association between patient survival and CIT. Only CIT hours 4-5 protected against mortality, and lower CIT times were not significantly different from the reference group of 6-7 hours of CIT. Similarly, only CIT between 11 and 14 demonstrated statistically significantly increased risk for mortality compared with the reference group. Furthermore, the effect observed with these CIT groups, although statistically significant, was small with a minimum HR of 0.94 and peak HR of 1.26. Although graft loss was more consistently associated with CIT, a similarly limited effect of CIT was observed in regards to this outcome with a minimum HR of 0.89 observed with 2-3 hours of CIT and a maximum HR of 1.33 observed with 15-16 hours of CIT.
In a more complete clinical picture, prior risk analysis of CIT alongside other donor and patient variables reveals several interactions. Although the use of grafts from elderly donors does increase graft loss alone, it has been previously demonstrated that elderly grafts with prolonged cold ischemia have increased risk for graft loss at 5 years. (14, 15) It has also been shown that grafts with prolonged cold ischemia have lower graft survival when transplanted in moderate-and high-MELD recipients but not when transplanted in low-MELD recipients. (15) Given the clear potential for confounding, our analysis controlled for numerous variables to isolate the effect of CIT. Nevertheless, clinicians must consider the complex interactions between CIT and multiple recipient and donor risk factors when interpreting the results of this study and its implications for organ selection and allocation.
Beyond survival measures, recipient length of stay following transplantation may serve as an additional outcome measure that captures morbidity, postoperative complications, and health care costs with greater sensitivity than patient and graft survival. (2) (3) (4) (5) (6) (7) Lifetime health care expenses per patient are estimated to total $0.5 million for each of the over 7000 liver transplants performed yearly in the United States. (16) Understanding factors that predict PLOS then not only prevents patient morbidity but also improves resource allocation from a population perspective. Although other pretransplant risk factors such as high MELD score have been associated with increased posttransplant length of stay and cost, the existing literature on the impact of CIT on length of stay and other nonsurvival outcome measures is largely inconsistent. (12, 13, 17) One study reported significant doubling of length of stay when CIT exceeded 18 hours. (13) The effect of CIT of >12 hours, however, failed to reach significance. Another study using 2.5-hour intervals of CIT failed to show association between CIT and PLOS. (12) Our hour-by-hour analysis of CIT revealed that PLOS was highly sensitive to small changes in CIT and demonstrated a positive correlation between posttransplant length of stay and CIT. Unlike factors such as age, cause of death, or race, CIT is unique as a donor variable that can be modified. Transplant centers, therefore, should strive to minimize CIT in order to achieve the greatest degree of protection against posttransplant PLOS, rather than relying on a maximum "safe" CIT cutoff. Beyond intuitive quality of life implications, the significance of PLOS also extends to health care costs. PLOS has been validated as a surrogate for resource usage among liver transplant patients, with each additional day of posttransplant hospitalization increasing perioperative costs by approximately $4257. (7, 18) Furthermore, although CIT itself has not been directly associated with increased rates of readmission, PLOS after liver transplantation has been associated with increased rates of readmission, further increasing morbidity for the recipient and cost for the health care system. (19) This study is limited by its retrospective nature. Additionally, although this study was designed to account for an extensive list of potential confounding variables, it is possible that some confounding variables were not captured by the database and therefore could not be entered into the multivariate model. Potential confounders unaccounted for could include intraoperative complications and blood product usage, difficult or prolonged hepatectomy phase, or allocation delays. Such complications could mediate poor postoperative outcomes due to ensuing renal dysfunction, prolonged intubation, or need for reoperation. Lastly, though the authors aimed to conduct this analysis in an objective fashion, the decision to use hourly increments of CIT was a subjective determination because this seemed like the smallest increment that could easily be used to guide clinical decision making and patient counseling. Similarly, the definition of PLOS as >30 days was based on prior literature that used this definition, though ultimately this definition is subjective.
In conclusion, we found that post-liver transplant PLOS is associated with CIT. Nearly every hour delay in CIT increases the risk for posttransplant PLOS, which represents increased morbidity for the recipient and increased cost for the health care system. Transplant centers, therefore, should aim to minimize CIT in order to optimize patient outcomes and minimize costs. Nevertheless, longer CIT should not preclude allocation, and recipients should be counseled regarding the associated risk for posttransplant PLOS.
